Cancel
Known information
- Received her PhD from the University of Colorado where she focused on the mechanisms of RNA Pol II mediated transcription
- Collaborated with Syros Pharmaceuticals on a novel CDK7 inhibitor
- Focuses on target discovery and validation for transcriptional addiction mechanisms in cancer
About Arpeggio Bio
Arpeggio Bio, based in Boulder, CO, specializes in drug discovery targeting transcription factors with AI and RNA-sequencing technologies. The company, with a team of 20, collaborates with industry giants like J&J and FORMA, focusing on diseases such as IO-resistant melanoma and rare genetic disorders.
Report inaccurate information
